Safety of ADU-1604 in Adults With Metastatic Melanoma

Summary

This study is a first-in-human, open-label, multicenter, dose-escalation study designed to evaluate the safety, PK, and PD of ADU-1604 and explore initial clinical activity in adults with metastatic melanoma.

Timeline

Start

2018-11-08

Primary completion

2019-08-09

Completion

2019-08-09

Outcome

Outcome not reported

Stopped (Business): “Study terminated due to business realignment”

Drugs

Indications